I-Mab’s pipeline pivot had a sting in the tail. Weeks after shifting its focus, the biotech said Wednesday that it has reduced its workforce by around 27% in conjunction with the pipeline ...
BioNTech is set to acquire MAB Discovery’s antibody generation unit. The deal will give the German mRNA specialist exclusive access to a unit it has worked with for the past five years. When BioNTech ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** My father was a World War II ...
The long journey from cell culture to a purified monoclonal antibody (mAb) involves many sample processing steps, with clarification and filtration playing significant roles. However, clogs, complex ...
ROCKVILLE, Md., Aug. 01, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the ...
Sept 22 (Reuters) - China-based biotech company I-Mab (IMAB.O), opens new tab said on Friday that AbbVie (ABBV.N), opens new tab has terminated a 2020 deal to co-develop and market I-Mab's lead cancer ...
I-Mab has completed enrollment ahead of schedule in the first cohort of its Phase 1b dose expansion study, which evaluates the bispecific antibody givastomig for treating gastric cancer. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback